Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2025-12-24 @ 3:25 PM
NCT ID:
NCT00667992
Eligibility Criteria:
Inclusion Criteria:
* Patients suffering from stable, persistent, mild to moderate asthma as defined by Global Initiative for Asthma (GINA) Guidelines and for whom FEV1 \> 60 %
* ICS taking ≤ 1000 μg BDP per day, or equivalent
* Methacholine PC20 \< 4 mg/mL
Exclusion Criteria:
* Known or suspected hypersensitivity to budesonide or any other constituents of the budesonide HFA pMDI or budesonide CFC pMDI.
* Currently a smoker or who has ceased smoking within 6 months of Visit 1.
* Exacerbations of asthma requiring oral steroids, hospitalisation or change in asthma therapy in the previous three months.
* Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or bronchiectasis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00667992
Study Brief:
Protocol Section:
NCT00667992